XM does not provide services to residents of the United States of America.

Australia's Novonix gets $755 mln US loan commitment to build graphite plant in Tennessee



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Australia's Novonix gets $755 mln US loan commitment to build graphite plant in Tennessee</title></head><body>

Adds details throughout from second paragraph

By Melanie Burton

MELBOURNE, Dec 17 (Reuters) -Novonix NVX.AX said on Tuesday it has secured a conditional $754.8 million loan commitment from the U.S. government to partially fund a proposed graphite plant in Tennessee, under the Advanced Technology Vehicles Manufacturing Loan Program.

The company's shares rallied as much as 16% on Tuesday after it announced the conditional commitment from the U.S. Department of Energy.

At full capacity, the proposed facility in Chattanooga is expected to produce about 31,500 metric tons a year of synthetic graphite, which can support the production of lithium-ion batteries for about 325,000 EVs each year, Novonix said.

The new facility is expected to reach full production capacity by the end of 2028.

The announcement has come in the same month as China tightened restrictions around graphite exports to the U.S., part of tougher measures that included export bans on "dual use" strategic metals including gallium and germanium.

"Recent announcements from China to further scrutinize the export of battery-grade graphite to the United States highlight the importance of domestic production of high-performance, battery-grade synthetic graphite," said CEO Chris Burns.

Novonix has signed offtake agreements with Panasonic Energy Co, Stellantis STLAM.MI, and Volkswagen VOWG_p.DE batterymaker PowerCo SE.

The company plans to expand the production capacity at the site to 75,000 tons a year of synthetic graphite, depending on customer demand and access to additional financing, it said.





Reporting by Melanie Burton in Melbourne and Roshan Thomas in Bengaluru; Editing by Shreya Biswas and Sonali Paul

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.